SEPTIN4 and neoplasm: The limited availability of potent and selective MART inhibitors has positioned in silico modeling, omics-based approaches, and the generation of knockout (KO) and transient experimental models as the primary strategies for elucidating the roles of MARTs in carcinogenesis and tumor progression.